Search

everythinglearnresearchcommunity

for

Search:↓

This type of hair loss is probably often missed and treatments reducing inflammation might work well.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

No single treatment is clearly effective for central serous chorioretinopathy.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Adults with trichotillomania do not have different pain sensitivity to cold pressor pain compared to healthy individuals.

Platelet-Rich Plasma (PRP) has potential benefits in plastic surgery, especially for skin grafts, wound healing, hair loss, mild Carpal Tunnel Syndrome, and TMJ disorders, but more research is needed to confirm its effectiveness.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Polycystic Ovary Syndrome (PCOS) is common in infertile women and obese women with PCOS have more severe ovulatory problems, needing more care.

Long COVID causes lasting symptoms and needs ongoing care.

Supplemented Erzhi Wan may help regrow hair in male pattern baldness by affecting certain cell signaling pathways.

People in palliative care often have skin problems due to their main illness or other health issues, and treatments focus on comfort and quality of life.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

A 16-year-old girl with HAIR-AN syndrome was treated with lifestyle changes and medications to manage her condition.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

No established treatment effectively stops inflammation and prevents hair loss in folliculitis decalvans.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.